{"id":"https://openalex.org/W4396997690","doi":"https://doi.org/10.1681/asn.20203110s1664b","title":"Dabrafenib-Induced Acute Interstitial Nephritis (AIN) and AKI in Patients with Cancer","display_name":"Dabrafenib-Induced Acute Interstitial Nephritis (AIN) and AKI in Patients with Cancer","publication_year":2020,"publication_date":"2020-10-01","ids":{"openalex":"https://openalex.org/W4396997690","doi":"https://doi.org/10.1681/asn.20203110s1664b"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20203110s1664b","doi":"https://doi.org/10.1681/asn.20203110s1664b","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1681/asn.20203110s1664b","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058591191","display_name":"Meghan D. Lee","orcid":"https://orcid.org/0000-0002-6895-5968","observed_orcids":["https://orcid.org/0000-0002-6895-5968"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meghan Lee","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084293710","display_name":"Harish Shanthanu Seethapathy","orcid":"https://orcid.org/0000-0002-1171-1022","observed_orcids":["https://orcid.org/0000-0002-1171-1022"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harish Shanthanu Seethapathy","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057132038","display_name":"Orhan Efe","orcid":"https://orcid.org/0000-0003-4852-9061","observed_orcids":["https://orcid.org/0000-0003-4852-9061"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Orhan Efe","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079203561","display_name":"Ian A. Strohbehn","orcid":"https://orcid.org/0000-0003-2167-2896","observed_orcids":["https://orcid.org/0000-0003-2167-2896"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ian A. Strohbehn","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001555365","display_name":"Nifasha Rusibamayila","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nifasha Rusibamayila","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011634251","display_name":"Ivy A. Rosales","orcid":"https://orcid.org/0000-0003-0621-3202","observed_orcids":["https://orcid.org/0000-0003-0621-3202"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivy Rosales","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019248592","display_name":"Robert B. Colvin","orcid":"https://orcid.org/0000-0002-4493-4150","observed_orcids":["https://orcid.org/0000-0002-4493-4150"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert B. Colvin","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050023158","display_name":"Donald F. Chute","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald F. Chute","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048669465","display_name":"Meghan E. Sise","orcid":"https://orcid.org/0000-0002-4327-9713","observed_orcids":["https://orcid.org/0000-0002-4327-9713"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meghan E. Sise","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210087915"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"10S","first_page":"664","last_page":"664"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.9595000147819519,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.9595000147819519,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.8960000276565552},{"id":"https://openalex.org/keywords/acute-interstitial-nephritis","display_name":"acute interstitial nephritis","score":0.9300000071525574},{"id":"https://openalex.org/keywords/drug-induced-nephrotoxicity","display_name":"drug-induced nephrotoxicity","score":0.875},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9279999732971191},{"id":"https://openalex.org/keywords/braf-v600-mutation","display_name":"BRAF V600 mutation","score":0.921999990940094},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.7889999747276306},{"id":"https://openalex.org/keywords/granulomatous-interstitial-nephritis","display_name":"granulomatous interstitial nephritis","score":0.9139999747276306},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9089999794960022},{"id":"https://openalex.org/keywords/liver-disease","display_name":"liver disease","score":0.6510000228881836},{"id":"https://openalex.org/keywords/aki-risk-factors","display_name":"AKI risk factors","score":0.7070000171661377},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.7110000252723694},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.4909999966621399},{"id":"https://openalex.org/keywords/kidney-biopsy","display_name":"renal biopsy","score":0.4950000047683716},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7053753137588501},{"id":"https://openalex.org/C2780888721","wikidata":"https://www.wikidata.org/wiki/Q1424106","display_name":"Interstitial nephritis","level":3,"score":0.6687995195388794},{"id":"https://openalex.org/C2777058396","wikidata":"https://www.wikidata.org/wiki/Q401402","display_name":"Nephritis","level":2,"score":0.5805376172065735},{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.5522253513336182},{"id":"https://openalex.org/C2780472472","wikidata":"https://www.wikidata.org/wiki/Q424337","display_name":"Acute kidney injury","level":2,"score":0.46953949332237244},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43774017691612244},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4189130365848541},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39261654019355774},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3308657109737396},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.09819108247756958},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.0},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20203110s1664b","doi":"https://doi.org/10.1681/asn.20203110s1664b","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1681/asn.20203110s1664b","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6399999856948853}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3116580032","https://openalex.org/W4403812111","https://openalex.org/W2896768205","https://openalex.org/W4396993681","https://openalex.org/W4415423731","https://openalex.org/W1909236391","https://openalex.org/W3180618583","https://openalex.org/W3044468087","https://openalex.org/W7152619743","https://openalex.org/W3164066392"],"abstract_inverted_index":{"Background:":[0],"BRAF":[1],"inhibitors":[2],"(vemurafenib,":[3],"dabrafenib,":[4],"encorafenib)":[5],"commonly":[6],"used":[7,96],"to":[8,34,97,204,289],"treat":[9],"BRAFV600":[10],"mutant":[11],"cancers":[12],"have":[13,27],"been":[14,28],"associated":[15],"with":[16,30,230,240,254,264],"AKI.":[17,101,169,268],"Cases":[18],"of":[19,41,53,100,153,173,189,195,199,224,235,267,291,297],"acute":[20],"and":[21,25,38,66,118,144,171,219,233,257],"chronic":[22],"tubular":[23],"injury":[24],"AIN":[26,248,298],"reported":[29],"dabrafenib.":[31,46,160,226,300],"We":[32,48],"aimed":[33],"define":[35],"the":[36,236],"incidence":[37],"clinical":[39],"features":[40],"AKI":[42,78,86,149,174,184,202,242,270],"in":[43,59,80,177,187,273],"patients":[44,54,105,146,193,274],"on":[45,275],"Methods:":[47],"conducted":[49],"a":[50,60,151,258],"retrospective":[51],"cohort":[52],"receiving":[55],"dabrafenib":[56,285],"from":[57],"2010-2018":[58],"large":[61],"healthcare":[62],"system.":[63],"Baseline":[64],"comorbidities":[65],"medication":[67],"use":[68],"was":[69,77,88,95,110,132,252],"determined":[70],"by":[71,90],"chart":[72],"review.":[73],"The":[74,227],"primary":[75],"outcome":[76],"(\u22651.5-fold-increase":[79],"baseline":[81,130,140,165],"creatinine)":[82],"within":[83,221],"12":[84],"months.":[85],"etiology":[87],"reviewed":[89],"2":[91],"nephrologists.":[92],"Multivariable":[93],"modeling":[94],"determine":[98],"predictors":[99],"Results:":[102],"Overall,":[103],"199":[104],"were":[106,116,120,185],"included;":[107],"mean":[108,152],"age":[109],"59":[111],"(SD":[112,134,155],"16)":[113],"years,":[114],"56%":[115],"male,":[117],"94%":[119],"white.":[121],"96%":[122],"received":[123],"trametinib":[124],"(a":[125],"MEK":[126],"inhibitor)":[127],"concurrently.":[128],"Mean":[129],"creatinine":[131],"0.9":[133],"0.2)":[135],"mg/dL,":[136],"20":[137],"(10%)":[138],"had":[139],"CKD":[141],"(eGFR<60":[142],"mL/min/1.73m2),":[143],"42":[145,190],"(21%)":[147],"experienced":[148,201,211],"at":[150],"141":[154],"116)":[156],"days":[157],"after":[158,284,299],"starting":[159,225],"In":[161],"multivariable":[162],"modeling,":[163],"only":[164],"liver":[166],"disease":[167],"predicted":[168],"Etiology":[170],"stage":[172],"are":[175],"shown":[176],"Fig":[178],"1A;":[179],"clear":[180],"alternative":[181],"causes":[182],"for":[183,261],"found":[186],"32":[188],"cases.":[191],"Ten":[192],"(5%":[194],"total":[196],"cohort,":[197],"24%":[198,290],"AKI)":[200],"attributed":[203],"dabrafenib-induced":[205],"cytokine":[206],"release":[207],"syndrome":[208],"(CRS);":[209],"all":[210],"fever,":[212],"chills,":[213],"gastrointestinal":[214],"distress":[215],"(nausea/vomiting/diarrhea)":[216],"+/-":[217],"rash":[218],"transaminitis":[220],"4-6":[222],"weeks":[223,263],"majority":[228],"improved":[229],"intravenous":[231,255],"hydration":[232],"discontinuation":[234],"drug.":[237],"One":[238],"patient":[239],"persistent":[241],"underwent":[243],"kidney":[244],"biopsy":[245],"demonstrating":[246],"granulomatous":[247],"(Fig":[249],"1B);":[250],"he":[251],"treated":[253],"solumedrol":[256],"prednisone":[259],"taper":[260],"two":[262],"full":[265],"resolution":[266],"Conclusions:":[269],"is":[271],"common":[272],"Dabrafenib":[276],"(21%).":[277],"A":[278],"febrile":[279],"systemic":[280],"response":[281],"or":[282],"CRS":[283],"may":[286],"explain":[287],"up":[288],"AKI;":[292],"we":[293],"report":[294],"another":[295],"case":[296],"Funding:":[301],"NIDDK":[302],"Support":[303]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-05-18T00:00:00"}